Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

News Features

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

May 19, 2025

Bloodlines: How Far Should Cardiologists Go in Treating Family?

News Features

Bloodlines: How Far Should Cardiologists Go in Treating Family?

March 10, 2022

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

December 20, 2021

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

The Cancer Patient Needing PCI Poses Conundrums for Care

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

January 14, 2020

EXCEL Investigators Respond to Data Suppression Claims As Debate Erupts Online

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

April 30, 2019

Top News in Imaging: 2018

News Features

Top News in Imaging: 2018

December 28, 2018

Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria

News Features

Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria

October 18, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

May 05, 2017

The Numbers Game: Door-to-Balloon or First Medical Contact? STEMI Care Still Needs Work Nationwide

News Features

The Numbers Game: Door-to-Balloon or First Medical Contact? STEMI Care Still Needs Work Nationwide

March 16, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.